• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Apnimed

Comfy bed sitting on pink clouds
Biotech

Shionogi pays Apnimed $100M for sleep disorder joint venture

Shionogi is taking full control of its sleep disorder joint venture, agreeing to pay Apnimed $100 million upfront for its partner’s stake.
Nick Paul Taylor Mar 24, 2026 9:20am
Bed floating on a cloud with the full moon behind it

Apnimed's sleep apnea star goes 2 for 2 in phase 3

Jul 23, 2025 6:00am
Comfy bed sitting on pink clouds

Apnimed eyes FDA sleep apnea submission after positive results

May 19, 2025 6:00am
chutes parachutes Turkey

Pfizer's migraine market chief joins Apnimed—Chutes & Ladders

Jan 26, 2024 9:30am
Wall Street stock exchange new York shares market

Two biotechs go public while Apnimed bides its time

Oct 2, 2023 11:02am
graphic of a bed illuminated atop a cloud

Apnimed nails study of sleep apnea med, tees up phase 3 test

May 22, 2023 10:45am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings